Jürgen Fichtl, Development Characterization Pharma Technical Development, Penzberg, Germany Mass Spec 2013, September 23-26, Boston

Size: px
Start display at page:

Download "Jürgen Fichtl, Development Characterization Pharma Technical Development, Penzberg, Germany Mass Spec 2013, September 23-26, Boston"

Transcription

1 Analytical Strategies for Assessment of Disulfide Linkages in Biopharmaceuticals Jürgen Fichtl, Development Characterization Pharma Technical Development, Penzberg, Germany Mass Spec 2013, September 23-26, Boston

2 Introduction Example 1: bispecific MAB Method description Research Clone Results of a research clone Results of the best producing clone Example 2: MAB with open SH Determination of free thiols Comparison with RP HPLC Determination of incorrect disulfide pairing Conclusions 2

3 Introduction IGG1 3

4 Introduction What disulfid modifications may occur? open sulfhydryl groups mainly in VL and CH3 ( Lacy ER et al 2008) Basic conditions may cause the formation of a non reducable thioether between HC - LC (J. Smith et al 2005) long term storage / posttranslational modification - may cause the formation of trisulfide within all inter chain bridges (S. Gu et al 2010) Heat stress conditions -may cause scrambling of C370 $ C96 (Yi Wang et al 2011) - fragmentation of hinge region (J. Vlasak et al 2007) Important role on function and stability IGG1 4

5 Introduction Analytical approaches Free thiols: - Reversed Phase Chromatography - Derivatization of free thiols with fluorimetric detection - Tryptic peptide map after derivatization of free thiols sum of all free thiols site-specific percentage of open disulfide bonds Incorrect disulfide pairing: - ESI-MS - Tryptic peptide map LCMS comparison before/after reduction poor sensitivity for minor species 5

6 Introduction Example 1: bispecific MAB Method description Research Clone Results of a research clone Results of the best producing clone Example 2: MAB with open SH Determination of free thiols Comparison with RP HPLC Determination of incorrect disulfide pairing Conclusions 6

7 Example 1: bispecific MAB Bispecific antibodies: Merge of two antibodies Ridgway JB, et al. (1996) 'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization. Protein Eng 9: Atwell S, et al. (1997) Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library. J. Mol. Biol. 270: desired mainproduct possible sideproduct 7

8 Sample preparation for LCMS peptide map Native tryptic digest (50µg antibody; c>2mg/ml) Alkylation of free SH: Buffer exchange: Digest (combination of LysC and Trypsin): - 1. Step: Addition of MAB : LysC 70:1 MAB : Trypsin 25:1-2.Step: Addition of MAB : Trypsin 25:1 Termination of digestion incubation 2h / 37 C incubation 16h / 37 C 8

9 Data evaluation LC MSMS on Thermo LTQ Orbitrap Top5 LCMSMS method (FT R=30.000; fragmentation in iontrap): Identification of SS-bridged peptides Dbond Algorithm (Seonhwa Choi et al 2009) : - java based software tool which screens all MSMS data to find b-/y- ions of SS bridged peptides - search based on local storage - workflow similar to mascot search (parameter files, modifications, fasta-file, excel export) Quantification by XIC evaluation relative determination of false SS-bridged peptides 9

10 Results: bispecific MAB of a research clone regular tryptic peptide (rel amount: 8%) 10

11 Results: bispecific MAB of a research clone regular tryptic peptide (rel amount: 8%) 11

12 Results: bispecific MAB of a research clone 12

13 Results: bispecific MAB of a research clone 13

14 Results: bispecific MAB of a research clone Int 37% 9% 25% 18% m/z 14

15 Results: bispecific MAB of a research clone 15

16 Results: bispecific MAB of a research clone Int 37% 9% 25% 18% m/z 16

17 Results: bispecific MAB of a research clone 17

18 Results: bispecific MAB of a research clone Quantification by SS bridge HC $ HC Description ratio HC1 366 HC2 343 HC1_$_HC2 88,0 HC2 343 HC2 343 HC2-Dimer 11,4 HC1 366 HC1 366 HC1_Dimer 0,6 18

19 Results: bispecific MAB of a research clone Int 37% 9% 25% 18% m/z 19

20 Results: bispecific MAB of a research clone Quantification by each cysteine SS Bond Description ratio LC1_Cys 213 LC1 213 HC1 232 LC1_$_HC1 27,7 LC1 213 HC2 214 LC1_$_HC2 49,6 LC1 213 LC1 213 LC1-Dimer 22,6 LC1 213 LC2 226 LC1_$_LC2 0,1 20

21 Results: bispecific MAB of a research clone Quantification by each cysteine SS Bond Description ratio LC1_Cys 213 LC1 213 HC1 232 LC1_$_HC1 27,7 LC1 213 HC2 214 LC1_$_HC2 49,6 LC1 213 LC1 213 LC1-Dimer 22,6 LC1 213 LC2 226 LC1_$_LC2 0,1 21

22 Results: bispecific MAB of a research clone RT: 4,17-9, ,83 TIC of native digest NL: 7,90E7 TIC F: ms MS f ,27 5,56 6,15 8,37 6,57 4,49 5,82 5,26 6,41 7,44 4,85 5,14 7,11 7,55 7,99 8,11 8,64 8,74 9,16 7,08 XIC of SS-peptide NL: 2,80E4 m/z= 507,18-507,21 F: ms MS f ,85 4,28 5,98 6,58 4,33 7,44 5,09 4,48 5,28 5,70 4,55 4,86 6,46 8,11 8,27 5,38 6,40 7,18 7,57 7,99 8,45 8,79 9,05 9,21 4,77 6,54 6,85 7,08 7,37 TIC of reduced digest XIC of SS-peptide NL: 2,69E7 TIC MS f NL: 7,36E2 m/z= 507,18-507,21 MS f ,5 5,0 5,5 6,0 6,5 7,0 7,5 8,0 8,5 9,0 Time (min) 22

23 Results: bispecific MAB of a research clone RT: 4,17-9, ,83 TIC of native digest NL: 7,90E7 TIC F: ms MS f ,27 5,56 6,15 8,37 6,57 4,49 5,82 5,26 6,41 7,44 4,85 5,14 7,11 7,55 7,99 8,11 8,64 8,74 9,16 7,08 XIC of SS-peptide NL: 2,80E4 m/z= 507,18-507,21 F: ms MS f ,85 4,28 5,98 6,58 4,33 7,44 5,09 4,48 5,28 5,70 4,55 4,86 6,46 8,11 8,27 5,38 6,40 7,18 7,57 7,99 8,45 8,79 9,05 9,21 4,77 6,54 6,85 7,08 7,37 TIC of reduced digest NL: 2,69E7 TIC MS f NL: 7,36E2 m/z= 507,18-507,21 MS f ,5 5,0 5,5 6,0 6,5 7,0 7,5 8,0 8,5 9,0 Time (min) 23

24 Introduction Example 1: bispecific MAB Method description Research Clone Results of a research clone Results of the best producing clone Example 2: MAB with open SH Determination of free thiols Comparison with RP HPLC Determination of incorrect disulfide pairing Conclusions 24

25 Results: Bispecific MAB of best producing clone - No incorrect disulfide linkages detected! - Disulfide linkages covered except for: peptides > 7000 Da (bad CID fragmentation data) peptide with two SS linkages peptide due to incomplete digest incomplete digest 25

26 Introduction Example 1: bispecific MAB Method description Research Clone Results of a research clone Results of the best producing clone Example 2: MAB with open SH Determination of free thiols Comparison with RP HPLC Determination of incorrect disulfide pairing Conclusions 26

27 Sample preparation In-house optimized reduced tryptic pepmap by derivatization with NEM/NEM-d5 0µg antibody; c>2mg/ml) Derivatization free SH with NEM Buffer Exchange to remove NEM Label concentrate by centrifugation Reduction of linked disulfides Derivatization of ne novo formed thiols with NEM-d5: Buffer Exchange to remove NEM-d5 Label Tryptic Digest Termination of Digestion 27

28 Example 2: Determination of free thiols C265 C230 C233 Peptid N NEM-d5 [%] N NEM [%] N SH [%] Peptid N NEM-d5 [%] N NEM [%] N SH [%] C22 65,59 34,41 n.n. C96 64,27 35,73 n.n. C149 H12 97,04 2,73 0,23 C204 99,65 n.n. 0,35 C224 99,42 0,58 n.n. C218 n.n. n.n. n.n. C230/ n.n. n.n. C230/ n.n. n.n. C265 94,83 4,9 0,27 C325 n.n. n.n. n.n. C371 95,43 4,39 0,18 C429 96,6 3,28 0,12 C23 96,78 3,14 0,08 C n.n. n.n. C n.n. n.n. C198 99,49 0,47 0,04 C325 C371 C429 28

29 Example 2: comparison with RP HPLC Ratio of free thiol LCMS ca 36% 41% 46% 13% calculated probability based on LCMS data 29

30 Example 2: Determination of incorrect disulfide pairing NEM-Tag C230 C233 SS Bond Description Ratio ph 7 C22 NEM HC_$_NEM 31.5 C22 C96 HC_$_HC 56.5 C22 C198 HC_$_LC 1.4 C22 C265 HC_$_LC 3.9 C22 minor species 3.0 C265 C325 C371 C429 30

31 Example 2: Determination of incorrect disulfide pairing NEM-Tag SS Bond Description Ratio ph 7 C96 NEM HC_$_NEM 47.4 C96 C22 HC_$_HC 48.7 C230 C233 C96 C265 HC_$_LC 1.6 C96 C371 HC_$_LC 1.0 C96 minor species 1.3 C265 C325 C C429

32 Introduction Example 1: bispecific MAB Method description Research Clone Results of a research clone Results of the best producing clone Example 2: MAB with open SH Determination of free thiols Comparison with RP HPLC Determination of incorrect disulfide pairing Conclusions 32

33 Conclusion Disulfide mismatching Native Tryptic Pepmap Evaluation by DBond - highly sensitive method to identify minor species of incorrect disulfide pairing - complex evaluation not practical for high troughput applications - induced scrambling during basic tryptic digest ESI-MS - high troughput application - not sensitive to minor species Free thiols - RP HPLC results correlate with tryptic peptide map with NEM/ NEM-d5 derivatization - tryptic peptide map with NEM/ NEM-d5 derivatization appropriate for identification of low ratios of free thiols

34 Acknoledgements Eunok Paek (University of Soeul; Dbond Algortithm) Nadja Alt Dietmar Reusch Nadine Flöser Manuel Schott Ingo Linder Andreas Adler

35 Doing now what patients need next 35

36 Example 2: Determination of Incorrect Disulfide Pairing Influence of Digest conditions C22 Label Area ph8,5 Area ph7 Area ph6 [%] [%] [%] HC_C96 30,1 56,5 52,5 HC_C265 12,1 3,9 0,8 LC_C198 14,2 1,4 0,2 HC_C148 13,4 0,9 0,1 LC_C138 9,8 0,8 0,1 HC_C325 2,6 0,6 0,1 HC_C371 5,5 0,3 0,1 LC_C23 5,3 0,2 0,0 HC_C22 1,1 0,2 0,0 HC_C224 1,3 0,1 0,0 HC_C429 1,0 0,0 0,0 LC_C92 1,0 0,0 0,0 HC_C204 0,3 0,0 0,0 NEM 2,1 35,1 46,1 C96 Label Area ph8,5 Area ph7 Area ph6 [%] [%] [%] HC_C22 36,8 48,7 34,0 HC_C265 7,3 1,6 0,6 HC_C371 10,9 1,0 0,2 LC_C198 15,7 0,4 0,1 LC_C138 4,0 0,4 0,0 HC_C325 2,6 0,3 0,0 HC_C148 6,8 0,2 0,1 HC_C429 7,4 0,0 0,0 HC_C224 1,4 0,0 0,0 HC_C96 0,6 0,0 0,0 HC_C204 0,4 0,0 0,0 NEM 6,3 47,4 64,9 36

37 ph 6.0 ph 7.0 ph 8.5 ph 6.0 ph 7.0 ph 8.5 ph 7.0 Compare of digest conditions MAB A native MAB B native MAB C native MAB D reduced kda kda

Highly Confident Peptide Mapping of Protein Digests Using Agilent LC/Q TOFs

Highly Confident Peptide Mapping of Protein Digests Using Agilent LC/Q TOFs Technical Overview Highly Confident Peptide Mapping of Protein Digests Using Agilent LC/Q TOFs Authors Stephen Madden, Crystal Cody, and Jungkap Park Agilent Technologies, Inc. Santa Clara, California,

More information

Utilizing novel technology for the analysis of therapeutic antibodies and host cell protein contamination

Utilizing novel technology for the analysis of therapeutic antibodies and host cell protein contamination Utilizing novel technology for the analysis of therapeutic antibodies and host cell protein contamination Kelli Jonakin, Ph.D. Senior Field Application Scientist, Seattle, WA Eric Johansen, Ph.D. Senior

More information

Analysis of Monoclonal Antibodies and Their Fragments by Size-Exclusion Chromatography Coupled with an Orbitrap Mass Spectrometer

Analysis of Monoclonal Antibodies and Their Fragments by Size-Exclusion Chromatography Coupled with an Orbitrap Mass Spectrometer Analysis of Monoclonal Antibodies and Their Fragments by ize-exclusion Chromatography Coupled with an Orbitrap Mass pectrometer hanhua Lin, Hongxia Wang, Zhiqi Hao, and Xiaodong Liu Thermo Fisher cientific,

More information

ProteinPilot Report for ProteinPilot Software

ProteinPilot Report for ProteinPilot Software ProteinPilot Report for ProteinPilot Software Detailed Analysis of Protein Identification / Quantitation Results Automatically Sean L Seymour, Christie Hunter SCIEX, USA Powerful mass spectrometers like

More information

Monoclonal Antibody Characterization on Q Exactive and Oribtrap Elite. Yi Zhang, Ph.D Senior Proteomic Marketing Specialist Oct.

Monoclonal Antibody Characterization on Q Exactive and Oribtrap Elite. Yi Zhang, Ph.D Senior Proteomic Marketing Specialist Oct. Monoclonal Antibody Characterization on Q Exactive and Oribtrap Elite Yi Zhang, Ph.D Senior Proteomic Marketing Specialist Oct. 12, 211 Outline Orbitrap Mass Spectrometer in mab Characterization Intact

More information

Analysis of Monoclonal Antibodies and Their Fragments by Size Exclusion Chromatography Coupled with an Orbitrap Mass Spectrometer

Analysis of Monoclonal Antibodies and Their Fragments by Size Exclusion Chromatography Coupled with an Orbitrap Mass Spectrometer Analysis of Monoclonal Antibodies and Their Fragments by Size Exclusion Chromatography Coupled with an Orbitrap Mass Spectrometer Shanhua Lin, 1 Hongxia Wang, 2 Zhiqi Hao, 2 Patrick Bennett, 2 and Xiaodong

More information

Basic protein and peptide science for proteomics. Henrik Johansson

Basic protein and peptide science for proteomics. Henrik Johansson Basic protein and peptide science for proteomics Henrik Johansson Proteins are the main actors in the cell Membranes Transport and storage Chemical factories DNA Building proteins Structure Proteins mediate

More information

Ensure your Success with Agilent s Biopharma Workflows

Ensure your Success with Agilent s Biopharma Workflows Ensure your Success with Agilent s Biopharma Workflows Steve Madden Software Product Manager Agilent Technologies, Inc. June 5, 2018 Agenda Agilent BioPharma Workflow Platform for LC/MS Intact Proteins

More information

ProMass HR Applications!

ProMass HR Applications! ProMass HR Applications! ProMass HR Features Ø ProMass HR includes features for high resolution data processing. Ø ProMass HR includes the standard ProMass deconvolution algorithm as well as the full Positive

More information

Biotherapeutic Non-Reduced Peptide Mapping

Biotherapeutic Non-Reduced Peptide Mapping Biotherapeutic Non-Reduced Peptide Mapping Routine non-reduced peptide mapping of biotherapeutics on the X500B QTOF System Method details for the routine non-reduced peptide mapping of a biotherapeutic

More information

Fast and Efficient Peptide Mapping of a Monoclonal Antibody (mab): UHPLC Performance with Superficially Porous Particles

Fast and Efficient Peptide Mapping of a Monoclonal Antibody (mab): UHPLC Performance with Superficially Porous Particles Fast and Efficient Peptide Mapping of a Monoclonal Antibody (mab): UHPLC Performance with Superficially Porous Particles Application Note Biotherapeutics and Biosimilars Authors James Martosella, Alex

More information

Spectral Counting Approaches and PEAKS

Spectral Counting Approaches and PEAKS Spectral Counting Approaches and PEAKS INBRE Proteomics Workshop, April 5, 2017 Boris Zybailov Department of Biochemistry and Molecular Biology University of Arkansas for Medical Sciences 1. Introduction

More information

ADVANCING ATTRIBUTE CONTROL OF ANTIBODIES AND ITS DERIVATIVES USING HIGH RESOLUTION ANALYTICS

ADVANCING ATTRIBUTE CONTROL OF ANTIBODIES AND ITS DERIVATIVES USING HIGH RESOLUTION ANALYTICS ADVANCING ATTRIBUTE CONTROL OF ANTIBODIES AND ITS DERIVATIVES USING HIGH RESOLUTION ANALYTICS Henry Shion 1, Jing Fang 1, William Alley 1, Barbara Sullivan 2, Nick Tomczyk 3, Liuxi Chen 1, Ying-Qing Yu

More information

The Peptide Mapping Games!

The Peptide Mapping Games! The Peptide Mapping Games! Introduction and Manual Sample Prep CSD Tim Rice, Paul Dinsmoor BioColumn Technical Specialists 1 Proteins and Monoclonal Antibodies Complex Molecules, Complex Manufacturing

More information

PAVING THE WAY FOR ASSESSING IN VIVO DYNAMICS OF MULTIPLE QUALITY ATTRIBUTES FOR PROTEIN THERAPEUTICS

PAVING THE WAY FOR ASSESSING IN VIVO DYNAMICS OF MULTIPLE QUALITY ATTRIBUTES FOR PROTEIN THERAPEUTICS PAVING THE WAY FOR ASSESSING IN VIVO DYNAMICS OF MULTIPLE QUALITY ATTRIBUTES FOR PROTEIN THERAPEUTICS CASSS Mass Spec September 21, 2017 Haihong Zhou Principal Scientist, Biologics, Vaccines & Bioanalytics

More information

Advanced QA/QC characterization MS in QC : Multi Attribute Method

Advanced QA/QC characterization MS in QC : Multi Attribute Method Advanced QA/QC characterization MS in QC : Multi Attribute Method Global BioPharma Summit The world leader in serving science A Complex Problem: Drug Safety and Quality Safety Is the product safe to use?

More information

Supplementary Table 1: List of CH3 domain interface residues in the first chain (A) and

Supplementary Table 1: List of CH3 domain interface residues in the first chain (A) and Supplementary Tables Supplementary Table 1: List of CH3 domain interface residues in the first chain (A) and their side chain contacting residues in the second chain (B) a Interface Res. in Contacting

More information

mabs and ADCs analysis by RP

mabs and ADCs analysis by RP mabs and ADCs analysis by RP Shanhua Lin, Ph.D. The world leader in serving science Protein and mab Separation by HPLC Size difference? YES Size Exclusion Chromatography (SEC) MAbPac SEC-1 NO NO Charge

More information

Chromatographic Workflows for Biopharmaceutical Characterization

Chromatographic Workflows for Biopharmaceutical Characterization Chromatographic Workflows for Biopharmaceutical Characterization Dr. Ken Cook European Bioseparation Sales Support Expert Thermo Fisher Scientific, Hemel Hempstead/Germany The world leader in serving science

More information

Rapid Peptide Mapping via Automated Integration of On-line Digestion, Separation and Mass Spectrometry for the Analysis of Therapeutic Proteins

Rapid Peptide Mapping via Automated Integration of On-line Digestion, Separation and Mass Spectrometry for the Analysis of Therapeutic Proteins Rapid Peptide Mapping via Automated Integration of On-line Digestion, Separation and Mass Spectrometry for the Analysis of Therapeutic Proteins Esther Lewis, 1 Kevin Meyer, 2 Zhiqi Hao, 1 Nick Herold,

More information

ZipChip TM. Microfluidic CE-ESI Biotherapeutics CE-ESI-MS Applications. Please visit us at

ZipChip TM. Microfluidic CE-ESI Biotherapeutics CE-ESI-MS Applications. Please visit us at ZipChip TM Microfluidic CE-ESI Biotherapeutics CE-ESI-MS Applications Please visit us at http://www.908devices.com/ // Actionable Intelligence HPMS & On-board Analytics / Slide 1 June 2016 // ZipChip CE-ESI

More information

Proteins. Patrick Boyce Biopharmaceutical Marketing Manager Waters Corporation 1

Proteins. Patrick Boyce Biopharmaceutical Marketing Manager Waters Corporation 1 Routine Characterization of mabs and Other Proteins Patrick Boyce Biopharmaceutical Marketing Manager Europe and India 2011 Waters Corporation 1 Agenda Why? What scientific challenges? Technology Example

More information

John Mehl, Bogdan Sleczka, Eugene Ciccimaro, Christian Caporuscio, Ekaterina Deyanova, Richard Huang, Timothy Olah, Celia D Arienzo

John Mehl, Bogdan Sleczka, Eugene Ciccimaro, Christian Caporuscio, Ekaterina Deyanova, Richard Huang, Timothy Olah, Celia D Arienzo Bioanalytical strategies for the quantitation of in-vivo site specific modifications of therapeutic antibodies in early discovery cyno studies using IP-LC-MS John Mehl, Bogdan Sleczka, Eugene Ciccimaro,

More information

Host Cell Protein Analysis Using Agilent AssayMAP Bravo and 6545XT AdvanceBio LC/Q-TOF

Host Cell Protein Analysis Using Agilent AssayMAP Bravo and 6545XT AdvanceBio LC/Q-TOF Application Note Biotherapeutics and Biosimilars Host Cell Protein Analysis Using Agilent AssayMAP Bravo and 6545XT AdvanceBio LC/Q-TOF Authors Linfeng Wu, Shuai Wu and Te-Wei Chu Agilent Technologies,

More information

Application Note. Authors. Abstract. Ravindra Gudihal Agilent Technologies India Pvt. Ltd. Bangalore, India

Application Note. Authors. Abstract. Ravindra Gudihal Agilent Technologies India Pvt. Ltd. Bangalore, India Quantitation of Oxidation Sites on a Monoclonal Antibody Using an Agilent 1260 Infinity HPLC-Chip/MS System Coupled to an Accurate-Mass 6520 Q-TOF LC/MS Application Note Authors Ravindra Gudihal Agilent

More information

BIOSIMILAR PROFILING SUMMER 2018 ANDREA DETLEFSEN

BIOSIMILAR PROFILING SUMMER 2018 ANDREA DETLEFSEN BIOSIMILAR PROFILING SUMMER 2018 ANDREA DETLEFSEN PROTEIN DRUGS Therapeutic proteins are one of the fastest growing categories of pharmaceuticals Ex: mabs, recombinant proteins As patents expire, biosimilars

More information

Comparability Analysis of Protein Therapeutics by Bottom-Up LC-MS with Stable Isotope-Tagged Reference Standards

Comparability Analysis of Protein Therapeutics by Bottom-Up LC-MS with Stable Isotope-Tagged Reference Standards Comparability Analysis of Protein Therapeutics by Bottom-Up LC-MS with Stable Isotope-Tagged Reference Standards 16 September 2011 Abbott Bioresearch Center, Worcester, MA USA Manuilov, A. V., C. H. Radziejewski

More information

Workflows for the Characterization of Glycan structure on Biotherapeutics

Workflows for the Characterization of Glycan structure on Biotherapeutics New Innovations in UHPLC and LC-MS Workflows for the Characterization of Glycan structure on Biotherapeutics Ken Cook EU Bio-Separations Support Expert April 2015 1 The world leader in serving science

More information

A Complete Workflow Solution for Intact Monoclonal Antibody Characterization Using a New High-Performance Benchtop Quadrupole- Orbitrap LC-MS/MS

A Complete Workflow Solution for Intact Monoclonal Antibody Characterization Using a New High-Performance Benchtop Quadrupole- Orbitrap LC-MS/MS A Complete Workflow Solution for Intact Monoclonal Antibody Characterization Using a New High-Performance Benchtop Quadrupole- Orbitrap LC-MS/MS Zhiqi Hao, 1 Yi Zhang, 1 David Horn, 1 Seema Sharma, 1 Shiaw-Lin

More information

Quantification of Host Cell Protein Impurities Using the Agilent 1290 Infinity II LC Coupled with the 6495B Triple Quadrupole LC/MS System

Quantification of Host Cell Protein Impurities Using the Agilent 1290 Infinity II LC Coupled with the 6495B Triple Quadrupole LC/MS System Application Note Biotherapeutics Quantification of Host Cell Protein Impurities Using the Agilent 9 Infinity II LC Coupled with the 6495B Triple Quadrupole LC/MS System Authors Linfeng Wu and Yanan Yang

More information

Characterization of intact monoclonal antibody with microfluidic chip electrophoresis mass spectrometry

Characterization of intact monoclonal antibody with microfluidic chip electrophoresis mass spectrometry POSTER NOTE 65 Characterization of intact monoclonal antibody with microfluidic chip electrophoresis mass spectrometry Authors Chien-Hsun Chen, 1 Andreas Krupke, 2 Stephane Houel, 1 Aaron Bailey, 1 Aran

More information

Strategies in proteomics

Strategies in proteomics Strategies in proteomics Systems biology - understand cellpathways, network, and complex interacting (includes Genomics, Proteomics, Metabolomics..) Biological processes - characterize protein complexes,

More information

Simple, Robust, High Quality Intact Mass Analysis A Biosimilars Case Study

Simple, Robust, High Quality Intact Mass Analysis A Biosimilars Case Study 3 Conjugation Site (ADC) 4 34 35 1 1 35 34 CASE STUDY 3 National Institute for Bioprocessing 3 4 Research and Training 1 35 31 5 31 3 6 9 3 9 5 6 7 7 6 8 8 3 1 19 16 17 19 18 7 9 11 11 5 17 9 7 3 1 9 9

More information

BioConfirm B Presentation

BioConfirm B Presentation BioConfirm B.08.00 Presentation 1 Major Enhancements to Increase Your Productivity The Latest Version of our BioConfirm Product, B.08.00 BioConfirm is protein and peptide characterization software using

More information

The world leader in serving science. Jonathan L. Josephs and Aaron O. Bailey. Life Sciences Mass Spectrometry

The world leader in serving science. Jonathan L. Josephs and Aaron O. Bailey. Life Sciences Mass Spectrometry Characterization of Monoclonal Antibodies Using UHPLC-HRAM MS The power of the Q Exactive BioPharma for online intact, subunit analysis, middle down, and peptide mapping Jonathan L. Josephs and Aaron O.

More information

A High Resolution Bench-Top Orbitrap LC-MS Workflow Solution for Comprehensive Intact Monoclonal Antibody Characterization

A High Resolution Bench-Top Orbitrap LC-MS Workflow Solution for Comprehensive Intact Monoclonal Antibody Characterization A High Resolution Bench-Top Orbitrap LC-MS Workflow Solution for Comprehensive Intact Monoclonal Antibody Characterization Zhiqi Hao, 1 David M. Horn, 1 Shiaw-Lin Wu, 2 Fan Zhang, 2 and Patrick Bennett

More information

Comprehensive characterization of three IgG forms using CESI-MS

Comprehensive characterization of three IgG forms using CESI-MS Comprehensive characterization of three IgG forms using CESI-MS Bryan Fonslow 1, Olga V. Friese 2, and K. Steven Cook 2 1 SCIEX, Brea, CA and 2 Pfizer, Chesterfield, MO mabs, ADCs, biosimilars, and biobetters

More information

基于质谱的蛋白质药物定性定量分析技术及应用

基于质谱的蛋白质药物定性定量分析技术及应用 基于质谱的蛋白质药物定性定量分析技术及应用 蛋白质组学质谱数据分析 单抗全蛋白测序及鉴定 Bioinformatics Solutions Inc. Waterloo, ON, Canada 上海 中国 2017 1 3 PEAKS Studio GUI Introduction Overview of PEAKS Studio GUI Project View Tasks, running info,

More information

Algorithm for Matching Additional Spectra

Algorithm for Matching Additional Spectra Improved Methods for Comprehensive Sample Analysis Using Protein Prospector Peter R. Baker 1, Katalin F. Medzihradszky 1 and Alma L. Burlingame 1 1 Mass Spectrometry Facility, Dept. of Pharmaceutical Chemistry,

More information

Liver Mitochondria Proteomics Employing High-Resolution MS Technology

Liver Mitochondria Proteomics Employing High-Resolution MS Technology Liver Mitochondria Proteomics Employing High-Resolution MS Technology Jenny Ho, 1 Loïc Dayon, 2 John Corthésy, 2 Umberto De Marchi, 2 Antonio Núñez, 2 Andreas Wiederkehr, 2 Rosa Viner, 3 Michael Blank,

More information

Investigating Biological Variation of Liver Enzymes in Human Hepatocytes

Investigating Biological Variation of Liver Enzymes in Human Hepatocytes Investigating Biological Variation of Liver Enzymes in Human Hepatocytes SWATH Acquisition on the TripleTOF Systems Xu Wang 1, Hui Zhang 2, Christie Hunter 1 1 SCIEX, USA, 2 Pfizer, USA MS/MS ALL with

More information

Biotherapeutic Peptide Mapping Information Dependent Acquisition (IDA) Method

Biotherapeutic Peptide Mapping Information Dependent Acquisition (IDA) Method Biotherapeutic Peptide Mapping Information Dependent Acquisition (IDA) Method Routine biotherapeutic accurate mass peptide mapping analysis on the X500B QTOF System Method details for the routine peptide

More information

Challenges in peptide mapping mass spectrometry of biopharmaceuticals

Challenges in peptide mapping mass spectrometry of biopharmaceuticals Challenges in peptide mapping mass spectrometry of biopharmaceuticals Will Burkitt, Ben Holmes, Johanna Paris, Nisha Patel, John O Hara 07.MAR.2018 Characterisation within UCB 2 Context to the type of

More information

Thermo Scientific Peptide Mapping Workflows. Upgrade Your Maps. Fast, confident and more reliable peptide mapping.

Thermo Scientific Peptide Mapping Workflows. Upgrade Your Maps. Fast, confident and more reliable peptide mapping. Thermo Scientific Peptide Mapping Workflows Upgrade Your Maps Fast, confident and more reliable peptide mapping. Smarter Navigation... Peptide mapping is a core analytic in biotherapeutic development.

More information

Disulfide Linkage Analysis of IgG1 using an Agilent 1260 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column

Disulfide Linkage Analysis of IgG1 using an Agilent 1260 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column Disulfide Linkage Analysis of IgG1 using an Agilent 126 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column Application Note Biotherapeutics & Biosimilars Author M. Sundaram

More information

Columns for Biomolecules BioLC Column Lines

Columns for Biomolecules BioLC Column Lines Columns for Biomolecules BioLC Column Lines Monoclonal Antibodies Glycans GlycanPac Nucleic Acids DNAPac Protein A Accucore Amide-HILIC DNAPac PA1 SEC-1 GlycanPac AXH-1 DNAPac PA2 SCX-1 GlycanPac AXR-1

More information

IRDye Infrared Dye Reagents

IRDye Infrared Dye Reagents IRDye Infrared Dye Reagents Technical Note IRDye 680LT Maleimide Labeling Application Guide Published March 2010. The most recent version of this Technical Note is posted at http://biosupport.licor.com/support

More information

Profiling Glycosylation of Monoclonal Antibodies at Three Levels Using the Agilent 6545XT AdvanceBio LC/Q TOF

Profiling Glycosylation of Monoclonal Antibodies at Three Levels Using the Agilent 6545XT AdvanceBio LC/Q TOF Application Note Biotherapeutics and Biosimilars Profiling Glycosylation of Monoclonal Antibodies at Three Levels Using the Agilent 64XT AdvanceBio LC/Q TOF Author David L. Wong Agilent Technologies, Inc.

More information

Phi29 Scaffold Has a Helix-Loop-Helix Motif and a Disordered Tail. Marc C Morais et al., Nature Structural Biology 2003

Phi29 Scaffold Has a Helix-Loop-Helix Motif and a Disordered Tail. Marc C Morais et al., Nature Structural Biology 2003 Phi29 Scaffold Has a Helix-Loop-Helix Motif and a Disordered Tail Marc C Morais et al., Nature Structural Biology 2003 Free scaffold 13+ 10 min 3 min 1 min 40 sec 100 % 0 100 % 0 100 % 0 100 % 0 Partially

More information

IMPROVE SPEED AND ACCURACY OF MONOCLONAL ANTIBODY BIOANALYSIS USING NANOTECHNOLOGY AND LCMS

IMPROVE SPEED AND ACCURACY OF MONOCLONAL ANTIBODY BIOANALYSIS USING NANOTECHNOLOGY AND LCMS IMPROVE SPEED AND ACCURACY OF MONOCLONAL ANTIBODY BIOANALYSIS USING NANOTECHNOLOGY AND LCMS As scientists gain an advanced understanding of diseases at the molecular level, the biopharmaceutical industry

More information

Quantitative mass spec based proteomics

Quantitative mass spec based proteomics Quantitative mass spec based proteomics Tuula Nyman Institute of Biotechnology tuula.nyman@helsinki.fi THE PROTEOME The complete protein complement expressed by a genome or by a cell or a tissue type (M.

More information

Characterization of a fusion protein under native and denaturing conditions with maxis II

Characterization of a fusion protein under native and denaturing conditions with maxis II Characterization of a fusion protein under native and denaturing conditions with maxis II Abstract The maxis II UHR-QTOF was used to characterize key attributes of a fusion protein in its native conformation

More information

PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mabs and ADC

PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mabs and ADC PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mabs and ADC Analysis of Intact and Fragmented mabs and ADC Application Note Biotherapeutics and Biologics Author Suresh Babu C.V. Agilent

More information

Strategies for Quantitative Proteomics. Atelier "Protéomique Quantitative" La Grande Motte, France - June 26, 2007

Strategies for Quantitative Proteomics. Atelier Protéomique Quantitative La Grande Motte, France - June 26, 2007 Strategies for Quantitative Proteomics Atelier "Protéomique Quantitative", France - June 26, 2007 Bruno Domon, Ph.D. Institut of Molecular Systems Biology ETH Zurich Zürich, Switzerland OUTLINE Introduction

More information

Objective. Introduction. IP assisted LC/MS/MS making study protein complexes easy. Jon Hao 1, Yi Liu 1, Xiaozhi Ren 2, and King-Wai Yau 2

Objective. Introduction. IP assisted LC/MS/MS making study protein complexes easy. Jon Hao 1, Yi Liu 1, Xiaozhi Ren 2, and King-Wai Yau 2 IP assisted LC/MS/MS making study protein complexes easy Jon Hao 1, Yi Liu 1, Xiaozhi Ren 2, and King-Wai Yau 2 1 Poochon Scientific, Frederick, Maryland 21701 2 Department of Neuroscience, Johns Hopkins

More information

iprg-2016 Proteome Informatics Research Group Study: Inferring Proteoforms from Bottom-up Proteomics Data

iprg-2016 Proteome Informatics Research Group Study: Inferring Proteoforms from Bottom-up Proteomics Data iprg-2016 Proteome Informatics Research Group Study: Inferring Proteoforms from Bottom-up Proteomics Data The ABRF iprg Research Group October 10, 2016 Dear iprg 2016 Study Participant, Thank you for participating

More information

A Highly Accurate Mass Profiling Approach to Protein Biomarker Discovery Using HPLC-Chip/ MS-Enabled ESI-TOF MS

A Highly Accurate Mass Profiling Approach to Protein Biomarker Discovery Using HPLC-Chip/ MS-Enabled ESI-TOF MS Application Note PROTEOMICS METABOLOMICS GENOMICS INFORMATICS GLYILEVALCYSGLUGLNALASERLEUASPARG CYSVALLYSPROLYSPHETYRTHRLEUHISLYS A Highly Accurate Mass Profiling Approach to Protein Biomarker Discovery

More information

Application Note LCMS-87 Automated Acquisition and Analysis of Data for Monitoring Protein Conjugation by LC-MS Using BioPharma Compass

Application Note LCMS-87 Automated Acquisition and Analysis of Data for Monitoring Protein Conjugation by LC-MS Using BioPharma Compass Application Note LCMS-87 Automated Acquisition and Analysis of Data for Monitoring Protein Conjugation by LC-MS Using BioPharma Compass Abstract Here we describe the development and use of an automated

More information

Supplementary information, Figure S1A ShHTL7 interacted with MAX2 but not another F-box protein COI1.

Supplementary information, Figure S1A ShHTL7 interacted with MAX2 but not another F-box protein COI1. GR24 (μm) 0 20 0 20 GST-ShHTL7 anti-gst His-MAX2 His-COI1 PVDF staining Supplementary information, Figure S1A ShHTL7 interacted with MAX2 but not another F-box protein COI1. Pull-down assays using GST-ShHTL7

More information

Bioanalytical LC-MS of monoclonal antibody therapeutics

Bioanalytical LC-MS of monoclonal antibody therapeutics Bioanalytical LC-MS of monoclonal antibody therapeutics William D van Dongen, product manager pharma bioanalysis small molecules immunogenicity 40 years experience in bioanalysis Bioanalytical Expertise

More information

Mass Spectrometry and Proteomics - Lecture 6 - Matthias Trost Newcastle University

Mass Spectrometry and Proteomics - Lecture 6 - Matthias Trost Newcastle University Mass Spectrometry and Proteomics - Lecture 6 - Matthias Trost Newcastle University matthias.trost@ncl.ac.uk Previously Quantitation techniques Label-free TMT SILAC Peptide identification and FDR 194 Lecture

More information

Advanced Characterization of Antibody Drug Conjugates (ADCs) by Liquid Chromatography and Mass Spectrometry (LC/MS) John Gebler, Ph.D.

Advanced Characterization of Antibody Drug Conjugates (ADCs) by Liquid Chromatography and Mass Spectrometry (LC/MS) John Gebler, Ph.D. Advanced Characterization of Antibody Drug Conjugates (ADCs) by Liquid Chromatography and Mass Spectrometry (LC/MS) John Gebler, Ph.D. Director www.waters.com/adc 2015 Waters Corporation 1 2015 Waters

More information

Demonstrating Biosimilarity of a Therapeutic Protein Product to a Reference Product ICH Guidance

Demonstrating Biosimilarity of a Therapeutic Protein Product to a Reference Product ICH Guidance Demonstrating Biosimilarity of a Therapeutic Protein Product to a Reference Product ICH Guidance Derek Bradley M.Sc. BioClin Research Laboratories 13 th May 2016 Agenda Brief overview of biosimilars ICH

More information

Towards an in vivo Stability Assay for ADCs and Their Metabolites in Serum by Affinity Capture LC-MS

Towards an in vivo Stability Assay for ADCs and Their Metabolites in Serum by Affinity Capture LC-MS Towards an in vivo Stability Assay for ADCs and Their Metabolites in Serum by Affinity Capture LC-MS mz (@Dr_mz13), PhD 11-Feb-2013 One of the challenges of ADCs includes the development of a method to

More information

Non-covalent or Native Mass Spectrometry. We can ionize intact protein complexes using ESI!!

Non-covalent or Native Mass Spectrometry. We can ionize intact protein complexes using ESI!! Non-covalent or Native Mass Spectrometry We can ionize intact protein complexes using ESI!! What Can We Learn? Stoichiometry of complex Relative affinity and topology Rates of subunit exchange Assembly

More information

Use of a Label-Free Quantitative Platform Based on MS/MS Average TIC to Calculate Dynamics of Protein Complexes in Insulin Signaling

Use of a Label-Free Quantitative Platform Based on MS/MS Average TIC to Calculate Dynamics of Protein Complexes in Insulin Signaling ABRF 2009 SELECTED PRESENTATIONS Use of a Label-Free Quantitative Platform Based on MS/MS Average TIC to Calculate Dynamics of Protein Complexes in Insulin Signaling Xuemei Yang, 1 Adam Friedman, 2 Shailender

More information

High Resolution Accurate Mass Peptide Quantitation on Thermo Scientific Q Exactive Mass Spectrometers. The world leader in serving science

High Resolution Accurate Mass Peptide Quantitation on Thermo Scientific Q Exactive Mass Spectrometers. The world leader in serving science High Resolution Accurate Mass Peptide Quantitation on Thermo Scientific Q Exactive Mass Spectrometers The world leader in serving science Goals Explore the capabilities of High Resolution Accurate Mass

More information

Increasing Throughput and Efficiency with Exactive LC/MS and Triple Quadrupole LC/MS/MS

Increasing Throughput and Efficiency with Exactive LC/MS and Triple Quadrupole LC/MS/MS Increasing Throughput and Efficiency with Exactive LC/MS and Triple Quadrupole LC/MS/MS Nicholas Duczak Thermo Scientific Annual Mass Spectrometry Users Meeting Somerset, NJ October 12th, 2011 Lead Finding

More information

Shotgun Proteomics: How Confident are you in that Identification? or Statistical Evaluation of Shotgun Proteomic Data

Shotgun Proteomics: How Confident are you in that Identification? or Statistical Evaluation of Shotgun Proteomic Data Shotgun Proteomics: How Confident are you in that Identification? or Statistical Evaluation of Shotgun Proteomic Data Ron Orlando Complex Carbohydrate Research Center University of Georgia Athens, GA 30602

More information

Easy Enhancements via Column Chemistry and Simplified Sample Preparation for Biosimilars. Joann Purkerson Thermo Fisher Scientific

Easy Enhancements via Column Chemistry and Simplified Sample Preparation for Biosimilars. Joann Purkerson Thermo Fisher Scientific Easy Enhancements via Column Chemistry and Simplified Sample Preparation for Biosimilars Joann Purkerson Thermo Fisher Scientific 1 Biopharma Analysis Workflows Discovery Development HRAM Identification

More information

Simultaneous Quantitation of a Monoclonal Antibody and Two Proteins in Human Plasma by High Resolution and Accurate Mass Measurements

Simultaneous Quantitation of a Monoclonal Antibody and Two Proteins in Human Plasma by High Resolution and Accurate Mass Measurements Simultaneous Quantitation of a Monoclonal Antibody and Two Proteins in Human Plasma by High Resolution and Accurate Mass Measurements Paul-Gerhard Lassahn 1, Kai Scheffler 2, Myriam Demant 3, Nathanael

More information

Key questions of proteomics. Bioinformatics 2. Proteomics. Foundation of proteomics. What proteins are there? Protein digestion

Key questions of proteomics. Bioinformatics 2. Proteomics. Foundation of proteomics. What proteins are there? Protein digestion s s Key questions of proteomics What proteins are there? Bioinformatics 2 Lecture X roteomics How much is there of each of the proteins? - Absolute quantitation - Stoichiometry What (modification/splice)

More information

Sasidhar N. Nirudodhi, Lin Tzihsuan, Justin Sperry, Jason C. Rouse, James A. Carroll

Sasidhar N. Nirudodhi, Lin Tzihsuan, Justin Sperry, Jason C. Rouse, James A. Carroll Impact of Sequence Variants on the Higher-Order Structure (HOS) of Monoclonal Antibodies Using an Optimized HDX- MS Method with a Dual-Protease Co-Immobilized Column Format Sasidhar N. Nirudodhi, Lin Tzihsuan,

More information

Advantages of Ion Mobility QTOF for Characterization of BioPharma Molecules

Advantages of Ion Mobility QTOF for Characterization of BioPharma Molecules Advantages of Ion Mobility QTOF for Characterization of BioPharma Molecules Add a New Dimension to your Research Capability with Agilent s New Drift Ion Mobility QTOF System David Wong, Ph.D. Sr. Application

More information

Monoclonal Antibody Analysis on a Reversed-Phase C4 Polymer Monolith Column

Monoclonal Antibody Analysis on a Reversed-Phase C4 Polymer Monolith Column Monoclonal Antibody Analysis on a Reversed-Phase C4 Polymer Monolith Column Shane Bechler 1, Ken Cook 2, and Kelly Flook 1 1 Thermo Fisher Scientific, Sunnyvale, CA, USA; 2 Thermo Fisher Scientific, Runcorn,

More information

N-Glycan Profiling Analysis of a Monoclonal Antibody Using UHPLC/FLD/Q-TOF

N-Glycan Profiling Analysis of a Monoclonal Antibody Using UHPLC/FLD/Q-TOF N-Glycan Profiling Analysis of a Monoclonal Antibody Using UHPLC/FLD/Q-TOF Application Note Authors Xianming Liu, Wei Zhang, Yi Du, Sheng Yin, Hong Que, and Weichang Zhou WuXi AppTec iopharmaceuticals

More information

Byos. A Clear Sky Solution for Analytical Scientists

Byos. A Clear Sky Solution for Analytical Scientists A Clear Sky Solution for Analytical Scientists One-touch Platform to Launch Seamless Workflows Raw File Report in Minutes Integrated application with templated workflows Workflows Step 1: Click to launch

More information

RockerBox. Filtering massive Mascot search results at the.dat level

RockerBox. Filtering massive Mascot search results at the.dat level RockerBox Filtering massive Mascot search results at the.dat level Challenges Big experiments High amount of data Large raw and.dat files (> 2GB) How to handle our results?? The 2.2 peptide summary could

More information

Barry Boyes 1,2, Tim Langlois 1, Brian Wagner 1, Stephanie Schuster 1 and Joe DeStefano 1

Barry Boyes 1,2, Tim Langlois 1, Brian Wagner 1, Stephanie Schuster 1 and Joe DeStefano 1 Barry Boyes 1,2, Tim Langlois 1, Brian Wagner 1, Stephanie Schuster 1 and Joe DeStefano 1 1. Advanced Materials Technology, Inc. Wilmington, Delaware, USA bboyes@advanced-materials-tech.com 2. Complex

More information

Využití cílené proteomiky pro kontrolu falšování potravin: identifikace peptidových markerů v mase pomocí LC- Q Exactive MS/MS

Využití cílené proteomiky pro kontrolu falšování potravin: identifikace peptidových markerů v mase pomocí LC- Q Exactive MS/MS Využití cílené proteomiky pro kontrolu falšování potravin: identifikace peptidových markerů v mase pomocí LC- Q Exactive MS/MS Michal Godula Ph.D. Thermo Fisher Scientific The world leader in serving science

More information

Agilent MassHunter BioConfirm Software NEW FRONTIERS IN THE CHARACTERIZATION OF BIOMOLECULES

Agilent MassHunter BioConfirm Software NEW FRONTIERS IN THE CHARACTERIZATION OF BIOMOLECULES Agilent MassHunter BioConfirm oftware NEW FRONTIER IN THE CHARACTERIZATION OF BIOMOLECULE NEW WORKFLOW FOR INTACT PROTEIN AND PROTEIN DIGET Biopharmaceutical discovery and development labs demand speed

More information

Generating Automated and Efficient LC/MS Peptide Mapping Results with the Biopharmaceutical Platform Solution with UNIFI

Generating Automated and Efficient LC/MS Peptide Mapping Results with the Biopharmaceutical Platform Solution with UNIFI with the Biopharmaceutical Platform Solution with UNIFI Vera B. Ivleva, Ying Qing Yu, Scott Berger, and Weibin Chen Waters Corporation, Milford, MA, USA A P P L I C AT ION B E N E F I T S The ability to

More information

Universal Solution for Monoclonal Antibody Quantification in Biological Fluids Using Trap-Elute MicroLC-MS Method

Universal Solution for Monoclonal Antibody Quantification in Biological Fluids Using Trap-Elute MicroLC-MS Method Universal Solution for Monoclonal Antibody Quantification in Biological Fluids Using Trap-Elute MicroLC-MS Method Featuring the SCIEX QTRAP 6500+ LC-MS/MS System with OptiFlow Turbo V source and M5 MicroLC

More information

Supplementary Figures

Supplementary Figures Supplementary Figures Supplementary Figure 1. FANCD2 Western blot. Lane 1 marker, lane 2 LN9SV, lane 3 LN9SV treated with hydroxyurea (HU), lane 4 GM6914, lane 5 GM6914 treated with HU, lane 6 VU697L,

More information

Asish Chakraborty, St John Skilton, Weibin Chen and John C. Gebler Waters Corporation, Milford, MA, U.S. INTRODUCTION METHODS. Sample preparation

Asish Chakraborty, St John Skilton, Weibin Chen and John C. Gebler Waters Corporation, Milford, MA, U.S. INTRODUCTION METHODS. Sample preparation Com p r e h ensiv e a n d Rou t in e C ha r ac t e riz at io n o f P rot eins a n d P e p t i d e s by LC/MS and LC/MS E Asish Chakraborty, St John Skilton, Weibin Chen and John C. Gebler Waters Corporation,

More information

Multi-Enzyme Digestion for Biotherapeutic Peptide Mapping: Examining BiopharmaLynx 1.3 Functionality

Multi-Enzyme Digestion for Biotherapeutic Peptide Mapping: Examining BiopharmaLynx 1.3 Functionality Multi-Enzyme Digestion for Biotherapeutic Peptide Mapping: Examining BiopharmaLynx 1.3 Functionality Scott J. Berger Waters Corporation, Milford, MA, USA TECHNOLOGY BENEFITS Enabling advanced multi-protease

More information

Separation of Native Monoclonal Antibodies and Identification of Charge Variants:

Separation of Native Monoclonal Antibodies and Identification of Charge Variants: Separation of Native Monoclonal Antibodies and Identification of Charge Variants: Teamwork of the Agilent 31 OFFGEL Fractionator, Agilent 21 Bioanalyzer and Agilent LC/MS Systems Application Note Biosimilar

More information

Application Note. Kwasi Antwi, Amanda Ribar, Urban A. Kiernan, and Eric E. Niederkofler Thermo Fisher Scientific, Tempe, Arizona

Application Note. Kwasi Antwi, Amanda Ribar, Urban A. Kiernan, and Eric E. Niederkofler Thermo Fisher Scientific, Tempe, Arizona Analysis of an Antibody Drug Conjugate using MSIA D.A.R.T. S. Technology, an Integral Part of Ligand Binding Mass Spectrometric Immunoassay (LB-MSIA) Workflow Application Note Kwasi Antwi, Amanda Ribar,

More information

A comprehensive CE/ESI-MS solution for BioPharma applications

A comprehensive CE/ESI-MS solution for BioPharma applications A comprehensive CE/ESI-MS solution for BioPharma applications Thermo Scientific Q Exactive hybrid quadrupole-orbitrap mass spectrometers with ZipChip system Fast CE Separation Nanospray Sensitivity HRAM

More information

Put the PRO in Protein Characterization

Put the PRO in Protein Characterization Put the PRO in Protein Characterization Aaron Boice LC/Q-TOF Product Manager 5-June-2017 Agenda The Right Tools for the Job Tackling Intact Proteins Break it Down Peptides and PTMs Sweet Success Released

More information

A highly sensitive and robust 150 µm column to enable high-throughput proteomics

A highly sensitive and robust 150 µm column to enable high-throughput proteomics APPLICATION NOTE 21744 Robust LC Separation Optimized MS Acquisition Comprehensive Data Informatics A highly sensitive and robust 15 µm column to enable high-throughput proteomics Authors Xin Zhang, 1

More information

Charge Variant Assessment of Nanobodies at the Intact Level by CESI-MS

Charge Variant Assessment of Nanobodies at the Intact Level by CESI-MS Charge Variant Assessment of Nanobodies at the Intact Level by CESI-MS Sensitive workflow for the detection of charge variants of nanobodies from small sample volumes Stephen Lock 1, Rob Haselberg 2, Raimond

More information

Analytical Characterization of Biotherapeutics: Looking to the Future with Biosimilars

Analytical Characterization of Biotherapeutics: Looking to the Future with Biosimilars Analytical Characterization of Biotherapeutics: Looking to the Future with Biosimilars Jared Auclair, Ph.D. Northeastern University Department of Chemistry and Chemical Biology Barnett Institute of Chemical

More information

Biochromatography Bring more Zen into your life and laboratory

Biochromatography Bring more Zen into your life and laboratory Seminar Biochromatography Bring more Zen into your life and laboratory Method development and maintaining peptide, protein, glycan and anti-body analyses by LC or LC-MS can be very time consuming and might

More information

Filter-based Protein Digestion (FPD): A Detergent-free and Scaffold-based Strategy for TMT workflows

Filter-based Protein Digestion (FPD): A Detergent-free and Scaffold-based Strategy for TMT workflows Supporting Information Filter-based Protein Digestion (FPD): A Detergent-free and Scaffold-based Strategy for TMT workflows Ekaterina Stepanova 1, Steven P. Gygi 1, *, Joao A. Paulo 1, * 1 Department of

More information

Enabling routine characterization of proteins. Agilent MassHunter BioConfirm software

Enabling routine characterization of proteins. Agilent MassHunter BioConfirm software Enabling routine characterization of proteins Agilent MassHunter BioConfirm software Bioconfirm a key component of your major biopharma workflows Intact protein analysis BioConfirm will rapidly deconvolute

More information

Application Note # ET-20 BioPharma Compass: A fully Automated Solution for Characterization and QC of Intact and Digested Proteins

Application Note # ET-20 BioPharma Compass: A fully Automated Solution for Characterization and QC of Intact and Digested Proteins Application Note # ET-20 BioPharma Compass: A fully Automated Solution for Characterization and QC of Intact and Digested Proteins BioPharma Compass TM is a fully automated solution for the rapid characterization

More information

Improving Sensitivity for an Immunocapture LC-MS Assay of Infliximab in Rat Plasma Using Trap-and-Elute MicroLC-MS

Improving Sensitivity for an Immunocapture LC-MS Assay of Infliximab in Rat Plasma Using Trap-and-Elute MicroLC-MS Improving Sensitivity for an Immunocapture LC-MS Assay of in Rat Plasma Using Trap-and-Elute MicroLC-MS Using the SCIEX M3 MicroLC system for Increased Sensitivity in Antibody Quantitation Remco van Soest

More information

ZipChip TM. Microfluidic CE-ESI Utility Life Sciences CE-ESI-MS Applications. Please visit us at

ZipChip TM. Microfluidic CE-ESI Utility Life Sciences CE-ESI-MS Applications. Please visit us at ZipChip TM Microfluidic CE-ESI Utility Life Sciences CE-ESI-MS Applications Please visit us at http://www.908devices.com/ // Actionable Intelligence HPMS & On-board Analytics / Slide 1 June 2016 // Presentation

More information

High-Throughput Peptide Mapping with the Vanquish UHPLC System and the Q Exactive HF Mass Spectrometer

High-Throughput Peptide Mapping with the Vanquish UHPLC System and the Q Exactive HF Mass Spectrometer High-Throughput Peptide Mapping with the Vanquish UHPLC System and the Q Exactive HF Mass Spectrometer Martin Samonig 1, Kai Scheffler 2, Remco Swart 1, and Jonathan Josephs 3 1 Thermo Fisher Scientific,

More information